[Asia Economy Reporter Kum Boryeong] Cha Biotech announced on the 8th that it has acquired a patent related to 'Stem Cell-Derived Skin Progenitor Cell Culture Medium and Its Manufacturing Method.'
Cha Biotech stated, "With the safe and optimized culture medium produced through this invention, we plan to utilize it as a raw material for various products that can improve skin tissue damage such as anti-aging, burns, and stretch marks, aiming to enter overseas markets," and added, "We also plan to apply it in the development of pharmaceuticals such as exosome therapies based on the culture medium."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

